Join us for an exclusive evening with Kelly George, where she will share her firsthand experience on how truBody devices have transformed her studio. Discover the innovative ways these devices have elevated her practice, improved client outcomes, and boosted business success. This roadshow promises an evening of networking, insightful discussions, and a deep dive into the latest advancements in body aesthetics, all complemented by delicious 3-course meals and drinks.
Kelly George is a Registered Cosmetic Nurse and the Founder of Kelly George Aesthetics, KGA Body, and KGA Clinic Coach. Kelly’s career in medical aesthetics began in 2006 with Allergan Australia. Her passion for helping patients achieve great skin and natural results has driven multiple successful businesses, including clinics in Tamworth and Sydney.
In 2018, Kelly won The Plastic Surgery Hub’s “Australia’s Favourite Injector” award and was named among the Ultimate 100 Global Aesthetic Leaders in 2019. She developed KGA Body, Australia’s first full range of active skincare for the body, and launched the podcast “Skin & Sass” in 2020 to provide honest information about skin and anti-aging treatments. Kelly also runs a successful coaching and mentoring business, helping clinic owners maximise their aesthetic businesses.
Date & Time: 22 October 2024 / 6:30 pm
Where: Ventuno Sydney
Address: 21 Hickson Rd, Walsh Bay NSW 2000
For further information please call Martin on +61 488 001 494 or email macollins@cutera.com
or Chrys on +61 410 476 867 or email cantoniou@cutera.com
Reference: 1. Data on file. Cutera Inc.
Long-lasting,
durable results1
Mild and transient
side effects2
Safe for all skin types, tones and severities in both adolescents and adults1
Three quick 30-minute treatment sessions, without downtime1
References: 1. Data on file. FDA clearance study. Cutera, Inc. 2. Data on file. Cutera, Inc.
*AviClear is also Health Canada approved for acne scars.
After image taken 12 months after final treatment session — Photo Courtesy of Cutera, Inc.
After image taken 6 months after final treatment session — Photo Courtesy of Cutera, Inc.
Patient results may vary.
Designed with input from leading dermatologists, the excel® V+ delivers the power, precision and performance to safely treat indications ranging from common skin concerns to challenging vascular and pigmentary conditions. Featuring two clinically proven wavelengths, large spot sizes up to 16mm, and higher energy, excel® V+ gives you the power to expand your treatment capabilities.
Features two clinically proven wavelengths that are preferentially absorbed by the chromophores of browns and reds, and fine lines/wrinkles.
truPulse technology uses the most advanced wavelength available to deliver higher energy at larger spot sizes and shorter pulse durations.
Deliver quick, efficient treatments with excel V+’s large 16mm spot size, or adjust spot sizes to precisely match the treatment area.
Adjustable from 5-20°C, excel V+’s superior contact cooling delivers consistent cooling before, during and after each pulse.
Number of Treatment(s): 4 — Photo Courtesy of D. Barco, MD
Photo Courtesy of L. Pain
Patient results may vary.
Tattoo and pigment removal is an essential part of every aesthetic practice. With a growing number of individuals experiencing tattoo regret, the market is expected to hit a year over year growth of 12.7% through 2023. Also, 40% of the population susceptible to pigmentary concerns and 71% of consumers are seeking tone and texture improvement.
The enlighten system is an industry-leading platform for tattoo removal and benign pigmented lesions. It is the first system on the market to feature both nanosecond and picosecond pulse durations and the ideal blend of parameters – the correct wavelengths, the correct spot sizes, and the correct energy levels – to effectively address unwanted pigment and ink.
Features three fully-integrated laser wavelengths to specifically target the multiple colors used in tattoos.
enlighten's combination of longer and shorter pulse durations enables efficient and effective reduction of pigment density.
Unique technology selectively shatters pigment and induces dermal disruption and skin revitalization in fewer than three sessions.
Combines the non-thermal picosecond pulse with a fractionated Micro Lens Array to address acne scars, wrinkles and unwanted pigmentation.
Number of Treatment(s): 4 — Photo Courtesy of Cutera
Number of Treatment(s): 3 — Photo Courtesy of Wayne Wertheim, M.D.
Patient results may vary.
Today, more than 92% laser and light-based treatments can be addressed with xeo. Cutera’s multi-engine, multi-application xeo platform is the ultimate aesthetic workstation, designed to give practices the power to grow—today, and for years to come.
xeo is a completely customisable laser and light-based system optimised to treat the widest range of today’s most common nonsurgical aesthetic concerns—veins, pigment, wrinkles, hair removal, and skin revitalisation with a single, robust aesthetic device.
Laser Genesis is a no-downtime, year-round aesthetic treatment, designed to help polish and perfect superficial skin revitalization concerns.
Among the top non-surgical procedures, laser hair removal is often considered a gateway procedure into the aesthetic market.
xeo's highly efficient technology enables fast and effective treatment of common, non-surgical aesthetic concerns.
Xeo's Pearl® techniques effectively and quickly target fine lines and wrinkles, enlarged pores, irregular skin quality and acne scarring.
Number of Treatment(s): 1 — Photo Courtesy of J. Kayal, M.D.
Number of Treatment(s): 7 — Photo Courtesy of R. Green, M.D.
Patient results may vary.
In recent years, the medical aesthetic industry has seen rapid growth in the number of body sculpting and body contouring procedures performed. The trend is projected to continue growing with the overall market growth of 16.3% year over year through 2020.
truSculpt (truSculpt iD) is the latest body sculpting treatment solution from cutera, providing a personalised, hands-free and hand-held solution to revolutionise your practice. This powerful, non-invasive, Monopolar RF platform tailors to patients’ individual needs and features Real-Time Temperature Control for clinically proven results. truSculpt treats the subcutaneous fat layer, resulting in an average of 24% fat reduction. It offers unique handpiece placement versatility and customised 15-minute protocols to treat a full abdomen and flanks simultaneously
truSculpt powerfully and non-invasively treats the subcutaneous fat layer, resulting in an impressive level of fat reduction.
The truSculpt offers customised 15-minute protocols that enable clients to enjoy quick, convenient and pain-free treatments.
With unique handpiece placement versatility and customised protocols, the abdomen and flanks can be treated at the same time.
Offering a range of handpieces, the truSculpt enables the targeting of traditionally difficult to treat areas.
Patient results may vary.
truFlex (truSculpt flex) is a muscle sculpting device that offers personalized treatments based on patient fitness level, shape, and goals. Only truFlex with Multi-Directional Stimulation (MDS) deploys a unique method of electrical muscle stimulation to target specific muscle groups using three treatment mode options, covering the largest treatment area in the body sculpting industry.
Bespoke muscle sculpting treatments tailored to each patient's unique fitness level, shape and aesthetic requirements.
truFlex's Multi-Directional Stimulation deploys a unique method of electrical muscle stimulation to target specific muscle groups.
Prep mode to warm up, tone mode to increase strength & endurance, and Sculpt mode to build muscle mass and increase basal metabolic rate.
Enables you to gain a competitive edge by delivering better, faster and safer results that drive patient satisfaction and practice growth.
Patient results may vary.
For further information please send us a message below.
24/1 O’Connell Street
Sydney NSW 2000, Australia
Tel: Australia +1800 288 372
New Zealand 0800 451 337
© 2024 Cutera ANZ. All rights reserved. Models are not actual patients.